Core Viewpoint - The company plans to acquire 100% equity of Guangzhou Yijie Medical Technology Co., Ltd. through a combination of issuing shares and cash payment, which is not expected to constitute a major asset restructuring or a restructuring listing [1][2] Group 1 - The transaction's audit and evaluation work is not yet completed, and the valuation and transaction price of the target assets have not been determined [1] - Based on preliminary calculations using financial data from both the listed company and the target company, the transaction is expected not to meet the standards for major asset restructuring as defined by the relevant regulations [1] - The company will provide a detailed analysis and disclosure regarding the determination of whether the transaction constitutes a major asset restructuring in the restructuring report [1] Group 2 - The controlling shareholder and actual controller of the listed company will remain Yuan Yuyu before and after the transaction [2] - There has been no change in control of the listed company in the past 36 months, and this transaction will not lead to a change in control, thus not constituting a restructuring listing as per the regulations [2]
迈普医学: 关于本次交易预计不构成重大资产重组、不构成重组上市的说明